Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Coming changes with ACOs intended to enhance savings, increase quality care
• The Yentl syndrome and gender inequality in ischemic HD C. Noel Bairey Merz, MD, FACC, FAHA
• Approval of new aortic valve allows use in thousands of CABG patients
• Bedside screening tool capable of detecting acute aortic dissection
• BEST: Blood urea nitrogen level may be linked to high-dose loop diuretic-associated mortality
• Cordis to exit drug-eluting stent market
• Diastolic dysfunction predicted mortality in patients with normal systolic function
• Effect of ablation devices on intracranial embolic events examined
• FDG-PET imaging illuminates role of inflammation in aortic stenosis
• Hypertension rate could be as high as 20% in young adults
• Iron deficiency not linked to CV, all-cause mortality
• Low vitamin D increased risk for arterial stiffness, endothelial dysfunction
• Multiple readings may be necessary for accurate BP measurement
• Organ dysfunction implicated in increased risk for HF
• Pause from CPR to defibrillator use critical factor in cardiac arrest survival
• PLATO: Aspirin dosage could explain regional discrepancies in ticagrelor efficacy
• Researchers find possible cause for high stroke rate in elderly after carotid stenting
• SIRTAX LATE: Comparable outcomes for sirolimus-, paclitaxel-eluting stents at 5 years
• Smoking during pregnancy could adversely affect children’s HDL levels
• Three recalls on defective CV devices announced
• VALOR II: Thoracic stent graft safe, efficacious in patients with descending TAA
• Warfarin recalled due to possible potency issue
• What the 2011 10Q Report means for women’s CV health Nanette K. Wenger, MD
• A new gene for ARVD Robert Roberts, MD, FRSC, FRCPC, MACC, LLD (Hon.), FAHA; Calvin W. Roberts, MD; William L. Roberts, MHA, CPA; Brandon A. Roberts, MSc, MD
• Drug-, device-induced effects on HF markers did not predict mortality benefit
• Healthy lifestyle led to low risk for sudden death in women
• Higher upfront cost of DES vs. BMS offset at 3 years
• PCI appropriateness in US varies from acute, non-acute indications
• Varenicline linked to increased chance for serious CV events
• Contrast agent improved patient comfort, reduced change in heart rate
• CREST: CAS, CEA performed by vascular surgeons led to similar outcomes
• Gender discrepancies observed in CAD detected by CTA
• Hospital-wide program promising for reduction of VTE events
• Noise reduction algorithm enhanced image quality in pediatric patients
• Sustained effectiveness of paclitaxel-eluting stent observed in patients with diabetes